Product Dossier
TRICORTONE
Product Dossier for TRICORTONE (triamcinolone acetonide, Aspen Pharmacare). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Aspen Pharmacare
- Active ingredient: triamcinolone acetonide
- Therapeutic area: Dermatology
- Related brand: ARCATUS
- Related brand: ARISTOCORT
- Related brand: OTOCOMB OTIC
- Same area: DERMATANE
- Same area: NEOTIGASON
What it is
TRICORTONE is a topical formulation containing triamcinolone acetonide 0.2 mg/g. It is available as both a cream and an ointment.
Approved indications
The provided source documents do not contain information about the approved indications for TRICORTONE topical formulations.
Dosing overview
The provided source documents do not contain dosing information for TRICORTONE topical formulations.
Key safety warnings
The provided source documents do not contain specific safety warning information for TRICORTONE topical formulations.
Contraindications
The provided source documents do not contain contraindication information for TRICORTONE topical formulations.
PBS listing
The provided source documents do not contain Pharmaceutical Benefits Scheme listing information for TRICORTONE.
Regulatory history
TRICORTONE 0.02% cream and 0.02% ointment were first listed on the Australian Register of Therapeutic Goods on 30 July 2003. Both formulations are sponsored by Aspen Pharmacare and hold licence category RE registration.